# Heron Therapeutics clinical trials: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with Heron Therapeutics as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Heron Therapeutics: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/heron-therapeutics

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 31, 2023 | NCT06109428 | Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011) | Heron Therapeutics | Phase 4 | Completed | Postoperative Pain, Abdominoplasty Surgery, Multimodal Analgesia | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06109428) |
| October 31, 2023 | NCT06109415 | Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011) | Heron Therapeutics | Phase 4 | Completed | Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06109415) |
| June 28, 2022 | NCT05434663 | Safety Study of Repeat Doses of SUSTOL in Adults | Heron Therapeutics | Phase 4 | Active not recruiting | Chemotherapy-Induced Nausea and Vomiting (CINV) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05434663) |
| November 5, 2021 | NCT05109312 | A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401. | Heron Therapeutics | Phase 4 | Active not recruiting | Analgesia | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05109312) |
| June 2, 2021 | NCT04911062 | HTX-011 in Spinal Surgery | Heron Therapeutics | Phase 2 | Completed | Post-Operative Pain, Lumbar Laminectomy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04911062) |
| July 14, 2020 | NCT04470622 | Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) | Heron Therapeutics | Phase 2 | Terminated | COVID-19 | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04470622) |
| May 21, 2020 | NCT04398329 | Dose-Escalation Study of HTX-034 Following Bunionectomy | Heron Therapeutics | Phase 1/2 | Completed | Bunions, Postoperative Pain | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04398329) |
| September 25, 2019 | NCT04102267 | Extended Delivery of Bupivacaine Study in Herniorrhaphy | Heron Therapeutics | Phase 4 | Completed | Analgesia | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04102267) |
| June 5, 2019 | NCT03974932 | Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen | Heron Therapeutics | Phase 3 | Completed | Analgesia | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03974932) |
| May 20, 2019 | NCT03955211 | PK and Safety After C-Section | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03955211) |
| April 19, 2019 | NCT03922048 | Pediatric Postoperative Analgesia Herniorrhaphy Study | Heron Therapeutics | Phase 2 | Withdrawn | Analgesia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03922048) |
| April 8, 2019 | NCT03907176 | Study of Post-Herniorrhaphy Non-opioid MMA Regimens | Heron Therapeutics | Phase 3 | Completed | Analgesia | 209 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03907176) |
| October 24, 2018 | NCT03718039 | Phase 2 Bunionectomy HTX-011 Administration Study | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03718039) |
| October 15, 2018 | NCT03705065 | Bupivacaine HCl PK and Safety in Augmentation Mammoplasty | Heron Therapeutics | Phase 4 | Completed | Postoperative Pain | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03705065) |
| October 4, 2018 | NCT03695367 | Phase 2 Herniorrhaphy Study for Opioid Elimination | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03695367) |
| September 28, 2017 | NCT03295721 | Bunionectomy Study for Postoperative Analgesia (EPOCH 1) | Heron Therapeutics | Phase 3 | Completed | Postoperative Pain | 412 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03295721) |
| August 2, 2017 | NCT03237481 | Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2) | Heron Therapeutics | Phase 3 | Completed | Postoperative Pain | 418 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03237481) |
| January 10, 2017 | NCT03015532 | Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03015532) |
| January 5, 2017 | NCT03011333 | Phase 2B Upper Extremity Nerve Block Study | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 243 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03011333) |
| May 5, 2016 | NCT02762929 | Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain, Bunions | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02762929) |
| February 23, 2016 | NCT02689258 | Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 277 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02689258) |
| July 22, 2015 | NCT02504580 | Pilot Herniorrhaphy Study for Postoperative Analgesia | Heron Therapeutics | Phase 2 | Completed | Postoperative Pain | 463 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02504580) |
| June 15, 2015 | NCT02471898 | HTX-011 for Post-bunionectomy Analgesia | Heron Therapeutics | Phase 2 | Completed | Analgesia | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02471898) |
| April 8, 2014 | NCT02106494 | A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC | Heron Therapeutics | Phase 3 | Completed | Chemotherapy-induced Nausea and Vomiting | 942 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02106494) |
| August 15, 2011 | NCT01416259 | A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin | Heron Therapeutics | Observational | Completed | Healthy | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01416259) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 1 |
| Phase 2 | 12 |
| Phase 3 | 6 |
| Phase 4 | 6 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Active not recruiting | 2 |
| Withdrawn | 1 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain, Postoperative | 20 |
| Agnosia | 8 |
| Hernia, Inguinal | 5 |
| Bunion | 4 |
| Hernia | 4 |
| Vomiting | 3 |
| Nausea | 1 |
| COVID-19 | 1 |
| Coronavirus Infections | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tobacco companies in the United States](https://specstream.ai/data/businesses/tobacco-companies/united-states)
- [Radiology practices in the United States](https://specstream.ai/data/businesses/radiology-practices/united-states)
- [Nepalese restaurants in the United States](https://specstream.ai/data/businesses/nepalese-restaurants/united-states)
- [Indonesian restaurants in the United States](https://specstream.ai/data/businesses/indonesian-restaurants/united-states)
- [Falafel restaurants in the United States](https://specstream.ai/data/businesses/falafel-restaurants/united-states)
- [College counseling companies in the United States](https://specstream.ai/data/businesses/college-counseling-companies/united-states)
